Cargando…
Is Metformin Use Associated With Decreased Thyroid Cancer Risk in Patients With Acromegaly?
Context: Acromegaly has long been blamed to portend an increased risk for benign and malignant thyroid neoplasia. Growth hormone (GH) and consequent insulin-like growth factor 1 (IGF-1) hypersecretion are implicated in cancer promotion. Metformin, a biguanide derived from the French lilac, is gainin...
Autores principales: | Kadioglu, Pinar, Sulu, Cem, Tay, Kubilay, Guzel, Suleyman, Sahin, Serdar, Durcan, Emre, Ozkaya, Hande Mefkure |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089607/ http://dx.doi.org/10.1210/jendso/bvab048.1763 |
Ejemplares similares
-
Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing’s disease
por: Durcan, Emre, et al.
Publicado: (2021) -
SUN-415 Is ‘’Visceral Adiposity Index’’ a Better Indicator of Metabolic Syndrome in Patients with Thyroid Nodules?
por: Durcan, Emre, et al.
Publicado: (2020) -
MON-293 The Prevalence of Impulse Control Disorders in Patients with Acromegaly and Prolactinomas Treated with Dopamine Agonists
por: Ozkaya, Hande Mefkure, et al.
Publicado: (2020) -
Pasireotide treatment in Cushing’s disease: A single tertiary center’s experience
por: ŞAHİN, Serdar, et al.
Publicado: (2021) -
A rare presentation of acromegaly: Hypercalcemia
por: Kara, Zehra, et al.
Publicado: (2023)